Trial Profile
A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cells19#iSCLife®-OA Therapy for Patients With Osteoarthritis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2024
Price :
$35
*
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
- 18 Apr 2024 Planned End Date changed from 1 Jun 2024 to 30 Jun 2025.
- 18 Apr 2024 Planned primary completion date changed from 1 Dec 2023 to 31 Dec 2024.
- 11 Apr 2023 Planned End Date changed from 1 Jun 2023 to 1 Jun 2024.